A Renaissance for Psychedelics Could Fill a Long-Standing Treatment Gap for Psychiatric Disorders
Psilocybin and MDMA represent a first wave of therapies that help patients by changing the way they view reality
Thomas R. Insel is a psychiatrist and neuroscientist who served as director of the National Institute of Mental Health from 2002 to 2015. He is an adviser to Compass Pathways, as well as to several digital mental health companies, and author of Healing: Our Path from Mental Illness to Mental Health (Penguin, 2022).
Psilocybin and MDMA represent a first wave of therapies that help patients by changing the way they view reality
A new study opens a door to more biologically based categories of major mental illness
A new study opens a door to more biologically based categories of major mental illness
Neuroscience is revealing the malfunctioning connections underlying psychological disorders and forcing psychiatrists to rethink the causes of mental illness
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account